Since we're the first up, I thought that would be appropriate. The issue we have chosen for discussion is the topic of mechanisms for approving new drugs and introducing them onto the market with respect to their therapeutic values, their side effects, their interactions with other drugs, etc., as well as a focus on clinical trials.
Nous avons décidé de parler des mécanismes d'homologation des nouveaux médicaments et de mise sur le marché, en tenant compte de leur valeur thérapeutique, de leurs effets secondaires, de leur interaction avec d'autres médicaments, etc., et en insistant sur les essais cliniques.